Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP3 | O14638 | 1/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23456483 | 0.70 | FADS1 (0.36) | ENPP3ENPP1ALDH1A1 | |
| SCHEMBL21623706 | 0.67 | KMO (0.37) | SMN1; SMN2 | |
| SCHEMBL29393159 | 0.66 | MAP3K14 (0.31) | — | |
| SCHEMBL20379172 | 0.65 | SCN5A (0.41) | GABRA1GABRG2GABRB3GABRA3 | |
| SCHEMBL23456467 | 0.64 | NPC1 (0.34) | ENPP3ENPP1GABRA1GABRG2GABRB3 | |
| SCHEMBL23456472 | 0.64 | FADS1 (0.36) | ALDH1A1 | |
| SCHEMBL107409 | 0.63 | PDE2A (0.33) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL15718231 | 0.61 | — | — | |
| SCHEMBL15655638 | 0.61 | — | — | |
| SCHEMBL6920105 | 0.61 | TGFBR1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322199-B | Compounds and their use in the treatment of schistosomiasis | 默克专利股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-118684667-A | Compounds for the treatment of fasciolopsis | 默克专利股份有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-112512636-B | Compounds for the treatment of fasciolopsis | 默克专利股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-115322199-A | Compounds and their use in the treatment of schistosomiasis | 默克专利股份有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-110461848-B | Compounds and their use in the treatment of schistosomiasis | 默克专利股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| EP-3823728-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF FASCIOLIASIS | Merck Patent GmbH (DE) | 2021-05-26 | — | — | EP | disclosed |
| CN-112512636-A | Compounds for the treatment of fascioliasis | 默克专利股份有限公司 | 2021-03-16 | — | — | CN | disclosed |
| WO-2020016235-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF FASCIOLIASIS | MERCK PATENT GMBH (DE) | 2020-01-23 | — | — | WO | disclosed |